Dr. Mark Catherwood

Consultant Clinical Scientist , Belfast City Hospital

Dr Mark Catherwood is a Consultant Clinical Scientist at Belfast City Hospital and is Head of Cancer Molecular Diagnostics, Regional Molecular Diagnostics Service, BHSCT and honorary lecturer at Queen's University Belfast and Ulster University. Mark is a member of ERIC (European Research Initiative on CLL) TP53 network that was established for the standardisation of TP53 analysis and a member of IgCLL (Immunoglobulin CLL) that has standardised IGHV mutational status in CLL. Mark is also a core member of EuroClonality which is a European consortium for the development of molecular diagnostic approaches to support the diagnosis and follow-up of haematological malignancies, particularly lymphoid malignancies. Mark's research interests are mainly on translational cancer research, particularly in the implementation of Next Generation Sequencing for molecular diagnostics. Mark has published more than 70 peer-reviewed papers in journals with high impact in molecular haematology and pathology.